AstraZeneca Faces New Class-Action Suit Over Prilosec Patent Expiration
U.K.-Swedish drug maker AstraZeneca is facing yet another class-action lawsuit over the way the company allegedly weaned patients off the ulcer drug Prilosec after its patent expired and on to its...To view the full article, register now.
Already a subscriber? Click here to view full article